Recover Investment Losses: Class Action Initiated Against Replimune Group, Inc. (REPL)
Levi & Korsinsky, LLP announced a securities class action lawsuit against Replimune Group, Inc. on behalf of investors who purchased shares between October 20, 2025, and April 10, 2026. The complaint alleges that defendants made false statements regarding FDA study design concerns and submitted insufficient data for the Biologics License Application involving RP1-104.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.